Cardio Diagnostics Holdings is trading at $1.86, up 8.77% in after-hours trading, with no clear August 10 catalyst identified.
- No company-specific announcement dated August 10, 2026 was identified in the company’s press-release archive.
- Latest reported earnings, published August 7, showed second-quarter sales of $0.00536 million and a $1.5 million net loss.
- An August 20 investor call, announced August 5, will discuss tests, reimbursement, studies and growth initiatives; the move is therefore unexplained rather than clearly earnings-driven.